An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial

by Nixon DR, Simonyi S, Bhogal M, Sigouin CS, Crichton AC, Discepola M, Hutnik CML, Yan DB
Published 2012

An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan® RC Early Analysis Review (CLEAR) trial

by Crichton AC, Nixon DR, Simonyi S, Bhogal M, Sigouin CS, Discepola MJ, Hutnik CML, Baptiste DC, Yan DB
Published 2014